Region Skane — Sponsor Intelligence | 32 EU Trials

Filter these 32 trials by condition, phase, country and more.

Open in Search →

32 Registered trials

13 Recruiting

14 Completed trials

10 Countries active

68 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 8 Phase II/III: 3 Phase II: 11 Phase III/IV: 2 Phase IV: 7 Phase I (FiH): 1

Oversight events:

1 serious breach across 1 trial

View oversight register →

100%

14 of 14 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Liposarcoma metastatic 1 Polymyalgia rheumatica 1 Systemic lupus erythematosus 1 Anhedonia 1 Dementia 1 Giant cell arteritis 1 Polyarthritis 1 Rheumatoid arthritis 1 Dedifferentiated liposarcoma 1 Neurodegenerative disorder 1 Progressive supranuclear palsy 1 C3 glomerulopathy 1

Top IMPs

2-(6-[18F]FLUORO-PYRIDIN-3-YL)-9H-DIPYRIDO[2,3-B:3',4'-D]PYRROLE 2 BENZYLPENICILLIN SODIUM 2 ADALIMUMAB 1 ADENOSINE 1 ALISKIREN 1 AMOXICILLIN, CLAVULANIC ACID 1 AMPICILLIN 1 ATORVASTATIN 1 CEFOTAXIME 1 CEFTRIAXONE SODIUM 1 CIPROFLOXACIN 1 CLOXACILLIN 1

All trials

32 total

Prophylactic Treatment of Graves Ophthalmopathy (GO) in Newly Diagnosed Graves' Disease (GD) with Atorvastatin (ATORGO) Pending

2023-504654-35-00 Phase II 1 country ATORVASTATIN
The therapeutic potential of psilocybin in anorexia nervosa in young adults Pending

2024-515163-63-00 Phase II 1 country DRY EXTRACT FROM PSILOCYBE CUBENSIS (15-25:1), EXTRACTION SOLVENT: METHANOL
Vaccination against respiratory syncytial virus in patients with inflammatory rheumatic diseases. The impact of anti-rheumatic treatments on… Pending

2024-518191-31-00 Phase IV 1 country RESPIRATORY SYNCYTIAL VIRUS, GLYCOPROTEIN F, RECOMBINANT, STABILISED IN THE PRE-…
Contrast Strategy In Fenestrated EndoVascular Aneurysm Repair Randomized Control Trial Pending

2025-521795-58-00 Phase III/IV 1 country IODIXANOL; IOHEXOL; IOMEPROL
IRONGIRLS-PILOT: Feasibility of Alternate-Day Iron Supplementation in Adolescent Girls Pending

2025-522498-12-00 Phase IV 1 country FERROUS SULFATE
Comparing intraoperative indocyanine green fluorescence imaging with standard clinical assessment for flap perfusion in head and neck recons… Pending

2025-524710-29-00 Phase IV 1 country INDOCYANINE GREEN
An Open-label Trial of Add-on Oral Slow-release Ketamine Treatment in Major Depression Recruiting

2025-524841-28-00 Phase II 1 country KETAMINE HYDROCHLORIDE
Neoadjuvant and postoperative treatment with dabrafenib and trametinib for papillary craniopharyngioma Recruiting

2024-517611-67-00 Phase II 1 country
HYPER-trial Hyperemic mYocardial Perfusion by adEnosine at diffeRent doses Recruiting

2023-505248-20-00 Phase IV 1 country ADENOSINE; GADOTERIC ACID
PERELI - A phase 2, open label study of PEmigatinib and REtifanlimab in advanced dedifferentiated Liposarcoma Recruiting

2022-501993-21-00 Phase II 3 countries PEMIGATINIB; RETIFANLIMAB
COMeBAC- COMparison between Bensypenicillin And Cloxacillin treatment in PSSA Recruiting

2023-506860-15-00 Phase IV 1 country BENZYLPENICILLIN SODIUM; CLOXACILLIN
Alternative antibiotics to multidrug-resistant UTIs Recruiting

2024-513294-41-00 Phase IV 1 country AMOXICILLIN, CLAVULANIC ACID; CIPROFLOXACIN; ERTAPENEM; PIVMECILLINAM HYDROCHLOR…
Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors. An open-label, multi-center, randomized phase III trial comparing safety a… Recruiting

2023-508572-11-00 Phase III 1 country LUTETIUM (177LU) EDOTREOTIDE
ERIS: EGFR-Mutated Lung Cancer in Randomized Investigator-Initiated Study Recruiting

2024-518172-31-01 Phase III 1 country
Accelerated treatment of infectious endocarditis Recruiting

2023-507652-76-00 Phase III/IV 1 country AMPICILLIN; BENZYLPENICILLIN SODIUM; CEFOTAXIME; CEFTRIAXONE SODIUM; CLOXACILLIN…
Positron emission tomography (PET) of patients with brain injury and athletes with concussion symptoms - Descriptive study of the tau tracer… Recruiting

2024-517048-67-00 Phase II 1 country 2-(6-[18F]FLUORO-PYRIDIN-3-YL)-9H-DIPYRIDO[2,3-B:3',4'-D]PYRROLE
Treatment of Graves´ ophthalmopathy with diclofenak or simvastatin Recruiting

2024-517833-42-00 Phase II/III 1 country
Stopping anti-TNF treatment in Crohn's and Colitis patients in remission Recruiting

2024-513299-17-00 Phase IV 1 country ADALIMUMAB; INFLIXIMAB
The BioFINDER 2 study - improved diagnostics and increased understanding of the pathophysiology of cognitive disorders Recruiting

2024-511842-38-00 Phase II 1 country 2-(6-[18F]FLUORO-PYRIDIN-3-YL)-9H-DIPYRIDO[2,3-B:3',4'-D]PYRROLE; FLUTEMETAMOL (…
Pramipexole in depression - a follow-up study Ended

2022-502270-17-00 Phase III 1 country
A trial to determine the safety and tolerability of transplanted stem cellderived dopamine neurons to the brains of individuals with Parkins… Ended

2024-511237-35-00 Phase I (FiH) 1 country
Adjuvant treatment with Pramipexole for anhedonia symptoms in depression - PRIME-PRAXOL Ended

2024-512495-35-00 Phase III 1 country
Acalabrutinib and rituximab in elderly patients with untreated mantle cell lymphoma (ALTAMIRA) Ended

2023-509864-96-00 Phase II 4 countries
Adjuvant instillations in intermediate risk NMIBC: A Study comparIng Gemcitabine and MitomYciN (SIGYN-trial) Ended

2023-504945-30-00 Phase III 1 country GEMCITABINE; MITOMYCIN

Showing 1–24 of 32 trials

← All sponsors A–Z